126 related articles for article (PubMed ID: 32507756)
1. [The Clinical, Pathological, and Genetic Correlation in Frontotemporal Lobar Degeneration].
Watanabe R; Arai T
Brain Nerve; 2020 Jun; 72(6):575-583. PubMed ID: 32507756
[TBL] [Abstract][Full Text] [Related]
2. Frontotemporal lobar degeneration: diversity of FTLD lesions.
Seilhean D; Bielle F; Plu I; Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
[TBL] [Abstract][Full Text] [Related]
3. [The molecular pathology of frontotemporal lobar degeneration].
Fujishiro H; Hasegawa M; Arai T
Seishin Shinkeigaku Zasshi; 2010; 112(4):313-24. PubMed ID: 20496755
[TBL] [Abstract][Full Text] [Related]
4. Distinct early symptoms in neuropathologically proven frontotemporal lobar degeneration.
Kawakami I; Arai T; Shinagawa S; Niizato K; Oshima K; Ikeda M
Int J Geriatr Psychiatry; 2021 Jan; 36(1):38-45. PubMed ID: 32748432
[TBL] [Abstract][Full Text] [Related]
5. Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features.
Gil MJ; Manzano MS; Cuadrado ML; Fernández C; Góméz E; Matesanz C; Calero M; Rábano A
J Alzheimers Dis; 2018; 63(3):1109-1117. PubMed ID: 29758948
[TBL] [Abstract][Full Text] [Related]
6. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
Urwin H; Josephs KA; Rohrer JD; Mackenzie IR; Neumann M; Authier A; Seelaar H; Van Swieten JC; Brown JM; Johannsen P; Nielsen JE; Holm IE; ; Dickson DW; Rademakers R; Graff-Radford NR; Parisi JE; Petersen RC; Hatanpaa KJ; White CL; Weiner MF; Geser F; Van Deerlin VM; Trojanowski JQ; Miller BL; Seeley WW; van der Zee J; Kumar-Singh S; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bigio EH; Deng HX; Halliday GM; Kril JJ; Munoz DG; Mann DM; Pickering-Brown SM; Doodeman V; Adamson G; Ghazi-Noori S; Fisher EM; Holton JL; Revesz T; Rossor MN; Collinge J; Mead S; Isaacs AM
Acta Neuropathol; 2010 Jul; 120(1):33-41. PubMed ID: 20490813
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
Lourenco GF; Janitz M; Huang Y; Halliday GM
Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
[TBL] [Abstract][Full Text] [Related]
8. Frontotemporal Lobar Degeneration.
Premi E; Padovani A; Borroni B
Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
[TBL] [Abstract][Full Text] [Related]
10. HnRNP Pathologies in Frontotemporal Lobar Degeneration.
Jiang X; Gatt A; Lashley T
Cells; 2023 Jun; 12(12):. PubMed ID: 37371103
[TBL] [Abstract][Full Text] [Related]
11. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
12. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
Davidson YS; Robinson AC; Hu Q; Mishra M; Baborie A; Jaros E; Perry RH; Cairns NJ; Richardson A; Gerhard A; Neary D; Snowden JS; Bigio EH; Mann DM
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):157-65. PubMed ID: 22497712
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers in frontotemporal lobar degenerations--progress and challenges.
Hu WT; Trojanowski JQ; Shaw LM
Prog Neurobiol; 2011 Dec; 95(4):636-48. PubMed ID: 21554923
[TBL] [Abstract][Full Text] [Related]
14. Review: Molecular pathology of frontotemporal lobar degenerations.
Borroni B; Alberici A; Buratti E
Neuropathol Appl Neurobiol; 2019 Feb; 45(1):41-57. PubMed ID: 30575981
[TBL] [Abstract][Full Text] [Related]
15. Expanding the Phenotype of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FUS).
Chornenka K; Hirsch-Reinshagen V; Perez-Rosendahl M; Feldman H; Segal-Gidan F; Vinters HV; Mackenzie IR
J Neuropathol Exp Neurol; 2020 Jul; 79(7):809-812. PubMed ID: 32483606
[TBL] [Abstract][Full Text] [Related]
16. Review: Neuropathology of non-tau frontotemporal lobar degeneration.
Neumann M; Mackenzie IRA
Neuropathol Appl Neurobiol; 2019 Feb; 45(1):19-40. PubMed ID: 30357887
[TBL] [Abstract][Full Text] [Related]
17. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
18. [Pathomechanisms and clinical aspects of frontotemporal lobar degeneration].
Bürger K; Arzberger T; Stephan J; Levin J; Edbauer D
Nervenarzt; 2017 Feb; 88(2):163-172. PubMed ID: 27999880
[TBL] [Abstract][Full Text] [Related]
19. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
[TBL] [Abstract][Full Text] [Related]
20. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
